Neurology Book

http://www.fpnotebook.com/

Levetiracetam

Aka: Levetiracetam, Keppra
  1. Indications
    1. Seizure Prophylaxis
    2. Second ot thrid line agent in Status Epilepticus
  2. Dosing
    1. Start: 500 to 1000 mg/day (max 4000 mg/day) divided twice daily
    2. Titrate every 2 weeks
    3. Target serum concentration: 12 to 46 mcg/ml
  3. Adverse Effects
    1. Agitation
    2. Anxiety
    3. Depressed mood
    4. Dizziness
    5. Fatigue
    6. Irritability
    7. Rash
    8. Somnolence
  4. References
    1. Liu (2017) Am Fam Physician 96(2): 87-96 [PubMed]
Medication Costs
levetiracetam (on 5/31/2017 at Medicaid.Gov Pharmacy Drug pricing)
LEVETIRACETAM 1,000 MG TABLET Generic $0.29 each
LEVETIRACETAM 100 MG/ML SOLN Generic $0.04 per ml
LEVETIRACETAM 250 MG TABLET Generic $0.09 each
LEVETIRACETAM 500 MG TABLET Generic $0.10 each
LEVETIRACETAM 750 MG TABLET Generic $0.17 each
LEVETIRACETAM ER 500 MG TABLET Generic $0.40 each
LEVETIRACETAM ER 750 MG TABLET Generic $0.54 each
keppra (on 2/22/2017 at Medicaid.Gov Pharmacy Drug pricing)
KEPPRA 1,000 MG TABLET Generic $0.29 each
KEPPRA 100 MG/ML ORAL SOLN Generic $0.04 per ml
KEPPRA 250 MG TABLET Generic $0.09 each
KEPPRA 500 MG TABLET Generic $0.10 each
KEPPRA 750 MG TABLET Generic $0.17 each
KEPPRA XR 500 MG TABLET Generic $0.40 each
KEPPRA XR 750 MG TABLET Generic $0.54 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Levetiracetam (C0377265)

Definition (NCI) A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
Definition (NCI_NCI-GLOSS) A drug used to treat seizures (involuntary muscle movements) caused by epilepsy (a group of brain disorders). Keppra is being studied in the treatment of seizures in patients with cancer that has spread to the brain. It is a type of anticonvulsant.
Definition (PDQ) A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=526173&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=526173&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47581" NCI Thesaurus)
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C026098
SnomedCT 323049001, 116076009, 387000003
LNC LP28566-5, MTHU014314
English (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, 1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,(S)-, levetiracetam, (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-,(S)-, levetiracetam (medication), LEVETIRACETAM, levETIRAcetam, LevETIRAcetam, Levetiracetam, Levetiracetam (product), Levetiracetam (substance), etiracetam, S-isomer
Spanish levetiracetam (producto), levetiracetam (sustancia), levetiracetam
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Keppra (C0876060)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C026098
English levetiracetam (Keppra), keppra, UCB Brand of Levetiracetam, Keppra
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree